Inspire Medical SystemsSTU:2DR +2.34%56 PS Ratio is 1.63 as of Jul. 08, 2026, which is 91% below its 10-year median of 17.21. GuruFocus rates STU:2DR with a GF Score™ of 56/100 and a GF Value™ of €189.30 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Inspire Medical Systems ranks better than 68.41% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, Inspire Medical Systems's share price is €43.80.
Inspire Medical Systems's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was €26.87. Hence, Inspire Medical Systems's PS Ratio for today is 1.63.
The historical rank and industry rank for Inspire Medical Systems's PS Ratio or its related term are showing as below:
STU:2DR'
s PS Ratio Range Over the Past 10 Years
Min: 1.28 Med: 17.21 Max: 54.08
Current: 1.6
During the past 11 years, Inspire Medical Systems's highest PS Ratio was 54.08. The lowest was 1.28. And the median was 17.21.
STU:2DR's PS Ratio is ranked better than 68.41% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 2.935
vs STU:2DR: 1.60
Inspire Medical Systems Inc revenue growth has slowed down over the past 12 months.
During the past 12 months, the average Revenue per Share Growth Rate of Inspire Medical Systems was 13.40% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 28.20% per year.
During the past 5 years, the average Revenue per Share Growth Rate was 46.80% per year.
During the past 10 years, the average Revenue per Share Growth Rate was 46.50% per year.
During the past 11 years, Inspire Medical Systems's highest 3-Year average Revenue per Share Growth Rate was 75.40% per year. The lowest was 27.90% per year. And the median was 41.55% per year.
Back to Basics: PS Ratio
Inspire Medical Systems (STU:2DR) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Inspire Medical Systems's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Inspire Medical Systems PS Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Inspire Medical Systems's PS Ratio distribution charts can be found below:
* The bar in red indicates where Inspire Medical Systems's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
Inspire Medical Systems's Share Price of today is €43.80. Inspire Medical Systems's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €26.87.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
Inspire Medical Systems (STU:2DR) has a PS Ratio of 1.63 as of Jul. 08, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Inspire Medical Systems and its competitors. This is 91% below median its historical median of 17.21. Over the past decade, Inspire Medical Systems' PS Ratio has ranged from 1.28 to 54.08. According to the industry distribution chart, Inspire Medical Systems ranks #254 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 31.6%.
Is Inspire Medical Systems' PS Ratio too high?
Inspire Medical Systems' current PS Ratio of 1.63 is 91% below median its 10-year median of 17.21. Over the past 10 years, this metric has ranged from a low of 1.28 to a high of 54.08. The Medical Devices & Instruments industry median PS Ratio is 2.94. Inspire Medical Systems' value of 1.63 is 44.5% below this industry median. Based on the distribution chart, Inspire Medical Systems ranks #254 out of 804 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Inspire Medical Systems has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Inspire Medical Systems' PS Ratio compare to ENOV and PRCT?
According to the Medical Devices & Instruments industry distribution chart, Inspire Medical Systems ranks #254 out of 804 companies for PS Ratio. This puts Inspire Medical Systems in the upper half of its industry. The industry median PS Ratio is 2.94. Inspire Medical Systems' value of 1.63 is 44.5% below this benchmark. Historically, Inspire Medical Systems' own PS Ratio has ranged from 1.28 to 54.08 over the past decade. While the company's 10-year median is 17.21 vs. the industry median of 2.94, Inspire Medical Systems has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Medical Devices & Instruments company?
The median PS Ratio among Medical Devices & Instruments companies is 2.94, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Inspire Medical Systems's current PS Ratio of 1.63 is 44.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on Inspire Medical Systems and its competitors. For the Medical Devices & Instruments industry, the median PS Ratio is 2.94 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Inspire Medical Systems's current PS Ratio is 1.63, which is 91% below median its own 10-year median of 17.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inspire Medical Systems stock overvalued right now?
Based on GuruFocus' analysis, Inspire Medical Systems (STU:2DR) is currently considered Possible Value Trap. The stock's GF Value™ is €189.30, compared to a current price of €43.80 — trading 76.9% below its estimated fair value. The current PS Ratio is 1.63, which is 91% below median its 10-year median of 17.21 and 44.5% below the Medical Devices & Instruments industry median of 2.94. Inspire Medical Systems' overall GF Score™ is 56/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For Inspire Medical Systems (STU:2DR), the current PS Ratio is 1.63 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Inspire Medical Systems (STU:2DR) Overvalued in 2026?
Based on GuruFocus' analysis, Inspire Medical Systems stock appears to be undervalued.
The current stock price of €43.80 is trading 76.9% below its estimated GF Value™ of €189.30.
GuruFocus considers Inspire Medical Systems to be Possible Value Trap.
Key valuation signals for STU:2DR:
PS Ratio: 1.63 (91% below median its 10-year median of 17.21)
GF Value™: €189.30 vs. price of €43.80 (76.9% below fair value)
Industry Position: 44.5% below the Medical Devices & Instruments median (#254 of 804)
No single metric tells the full story. See the STU:2DR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.
56GF Score
Get the complete analysis for STU:2DR
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:2DR has been successfully added to your 
